STEPHANIE HUFFMAN: Open Payments
NPI 1205526563 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,815 in 72 payments from 30 companies in 2025. Trend: 2023 $121 · 2024 $1,463 · 2025 $1,815
Food & beverage: $1,737Education: $78
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $440 |
| AstraZeneca Pharmaceuticals LP | 6 | $155 |
| Janssen Biotech, Inc. | 5 | $99 |
| Celgene Corporation | 4 | $86 |
| TerSera Therapeutics LLC | 3 | $84 |
| SEAGEN INC. | 1 | $78 |
| Aveo Pharmaceuticals, Inc. | 2 | $72 |
| TAIHO ONCOLOGY, INC. | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $53 |
Products named: KISQALI, Fabhalta, REBLOZYL, PLUVICTO, FOTIVDA, Xermelo, LONSURF, KEYTRUDA.
Industry payments across TN — which companies pay providers there.
